Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...